| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 唐寅灏 | 中信证券 | 医药生物 | 40.22% | 38.86% | 27.45% | 85.71% | 12 | -8.47% | 2025-06-26 |
| 2 | 杨松 | 天风证券 | 医药生物 | 40.20% | 42.50% | 27.21% | -40.89% | 19 | -72.65% | 2025-07-30 |
| 3 | 万鹏辉 | 国海证券 | 医药生物 | 40.15% | 40.02% | 22.03% | 50.00% | 5 | -3.00% | 2025-07-31 |
| 4 | 张林晚 | 上海证券 | 医药生物 | 40.14% | 43.62% | 35.34% | -100.00% | 1 | -18.93% | 2025-07-14 |
| 5 | 刘浩 | 华创证券 | 医药生物 | 40.14% | 33.73% | 41.75% | 29.41% | 2 | -47.33% | 2025-05-09 |
| 6 | 赵海春 | 国金证券 | 医药生物 | 40.07% | 43.03% | 50.44% | -25.00% | 2 | -61.07% | 2025-08-05 |
| 7 | 仰佳佳 | 申万宏源 | 医药生物 | 40.04% | 40.86% | 30.52% | 23.08% | 1 | -37.64% | 2025-06-09 |
| 8 | 李安飞 | 广发证券 | 医药生物 | 40.01% | 30.29% | 35.07% | -2.86% | 1 | -56.96% | 2025-05-14 |
| 9 | 赵海春 | 国金证券 | 医药生物 | 39.98% | 349.67% | 50.34% | -25.00% | 2 | -61.07% | 2025-08-04 |
| 10 | 华挺 | 财通证券 | 医药生物 | 39.93% | 38.46% | 13.73% | -6.67% | 7 | -50.33% | 2025-08-11 |
| 11 | 赵海春 | 国金证券 | 医药生物 | 39.85% | 44.90% | 36.20% | -25.00% | 2 | -61.07% | 2025-07-03 |
| 12 | 王斌 | 首创证券 | 医药生物 | 39.81% | 43.15% | 25.18% | 4.11% | 19 | -54.62% | 2025-08-05 |
| 13 | 万鹏辉 | 国海证券 | 医药生物 | 39.79% | 33.85% | 22.20% | 50.00% | 5 | -3.00% | 2025-08-12 |
| 14 | 张林晚 | 上海证券 | 医药生物 | 39.76% | 27.83% | 35.22% | -100.00% | 1 | -18.93% | 2025-06-13 |
| 15 | 华挺 | 财通证券 | 医药生物 | 39.73% | 38.06% | 15.61% | -6.67% | 7 | -50.33% | 2025-08-07 |
| 16 | 周豫 | 太平洋 | 医药生物 | 39.61% | 45.98% | 27.56% | 21.21% | 23 | -55.62% | 2025-07-22 |
| 17 | 王斌 | 首创证券 | 医药生物 | 39.61% | 43.37% | 25.00% | 4.11% | 19 | -54.62% | 2025-08-01 |
| 18 | 马云涛 | 国元证券 | 医药生物 | 39.60% | 44.45% | 27.43% | -17.65% | 1 | -47.07% | 2025-08-01 |
| 19 | 张林晚 | 上海证券 | 医药生物 | 39.57% | 44.42% | 37.77% | -100.00% | 1 | -18.93% | 2025-07-18 |
| 20 | 华挺 | 财通证券 | 医药生物 | 39.48% | 37.64% | 16.24% | -6.67% | 7 | -50.33% | 2025-08-12 |